The market is up 1.2% over the past week, with the Information Technology sector up 1.0%. Over the past year, the market is up 26%, and earnings are expected to grow 15% annually. In this favorable environment, it is critical for investors seeking robust returns to identify high-growth technology stocks that can capitalize on these trends.

The 10 fastest growing technology companies in the USA

Click here to see the full list of 248 stocks from our high-growth US tech and AI stocks screener.

Let’s uncover some gems from our specialized screener.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Flex Ltd. provides manufacturing solutions for various brands in Asia, America and Europe and has a market capitalization of $13.08 billion.

Operations: Flex Ltd. generates its revenue primarily from two segments: Flex Agility Solutions (US$13.69 billion) and Flex Reliability Solutions (US$12.15 billion). The company operates in Asia, the Americas and Europe and provides diverse manufacturing solutions for various brands.

Flex is making significant strides in the technology space, particularly with its recent $498.91 million fixed income offering and strategic collaboration with Musashi Energy Solutions. The company’s earnings are expected to grow 20.6% annually, outpacing the U.S. market at 15.2%. Flex’s R&D spending reflects a strong commitment to innovation, and its CESS technology aims to mitigate power fluctuations in AI data centers. From April to June 2024, Flex repurchased 15.29 million shares for $456.92 million, indicating robust financial health and a focus on shareholder value.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: GoodRx Holdings, Inc., together with its subsidiaries, provides tools and information that help consumers in the United States compare the prices of prescription drugs and save money when purchasing them. Its market capitalization is approximately $3.12 billion.

Operations: GoodRx Holdings generates its revenue primarily from its healthcare software division, which reported $775.09 million. The company focuses on providing consumers with tools and information to help them compare and save money on prescription drug prices in the United States.

The story continues

GoodRx Holdings is navigating a challenging environment with revenue growth forecast at 9.5% annually, easily outperforming the US market at 8.8%. Despite recent earnings forecast revisions, its R&D spending underscores its commitment to innovation in healthcare affordability initiatives. The company’s collaboration with Boehringer Ingelheim to offer adalimumab-adbm for $550 per two-pack represents a significant step toward reducing patient costs by 92%. Earnings are expected to grow at an impressive 50.84% ​​annually, indicating potential profitability within three years.

Simply Wall St Growth Rating: ★★★★★☆

Overview: Nutanix, Inc. provides an enterprise cloud platform in various global regions including North America, Europe, Asia Pacific, Middle East, Latin America, and Africa with a market capitalization of $13.16 billion.

Operations: Nutanix, Inc. generates revenue primarily from its Internet Software & Services segment and amounts to $2.10 billion. The company operates in several global regions and is focused on providing an enterprise cloud platform.

Nutanix’s revenue growth of 13.6% outpaces the US market’s 8.8% annual growth, reflecting its strong position in the technology sector. The company’s R&D expenditure of $290 million shows that the company has a strong focus on innovation and product development. Earnings are expected to grow an impressive 85.2% annually over the next three years, suggesting significant future profitability potential. Recent share buybacks totaling $106 million demonstrate confidence in long-term value creation for shareholders.

Next Steps

• Click here to access our full index of 248 high-growth U.S. technology and AI stocks.

• Are you a shareholder in one or more of these companies? Make sure you’re never caught off guard by adding your portfolio to Simply Wall St and receive timely alerts about important stock developments.

• Harness the power of informed investing with Simply Wall St, your free guide to navigating the world’s stock markets.

Curious about other options?

This Simply Wall St article is of a general nature. We comment solely on the basis of historical data and analyst forecasts, using an unbiased methodology. Our articles do not constitute financial advice. It is not a recommendation to buy or sell any stock and does not take into account your objectives or financial situation. Our goal is to provide you with long-term analysis based on fundamental data. Note that our analysis may not take into account the latest price-sensitive company announcements or qualitative materials. Simply Wall St does not hold any of the stocks mentioned.

Companies discussed in this article include NasdaqGS:FLEX, NasdaqGS:GDRX, and NasdaqGS:NTNX.

Do you have feedback on this article? Are you interested in the content? Contact us directly. Alternatively, send an email to [email protected]